Form 4 for DGX Quest Diagnostics
Accepted 2021-07-30 00:00:00 ET · period of report 2021-07-28 · accession 0001022079-21-000117 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-30 | 2021-07-28+ | DGX | RUSCKOWSKI STEPHEN H | COB, CEO, Pres, Dir | M - OptEx | $95.80 | +149.2K | 424.2K | +54% | +$14.30M |
| DM | 2021-07-30 | 2021-07-28+ | DGX | RUSCKOWSKI STEPHEN H | COB, CEO, Pres, Dir | S - Sale+OE | $140.19 | -149.2K | 284.4K | -34% | -$20.92M |
| DM | 2021-07-30 | 2021-07-28+ | DGX | RUSCKOWSKI STEPHEN H | COB, CEO, Pres, Dir | M - OptEx | $95.80 | -149.2K | 4,193 | -97% | -$14.30M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-29 | M | A | 4,193 | $95.80 | 288,620 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-29 | S | D | 4,193 | $141.22 | 284,427 | D | — | — | (F4) This transaction was executed in multiple trades at prices ranging from $141.06 to $141.43. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2021-07-28 | S | D | 139,751 | $140.14 | 284,427 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $140.00 to $140.62. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Common | Common Stock | 2021-07-29 | S | D | 5,300 | $140.59 | 284,427 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $140.06 to $141.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 5 | Common | Common Stock | 2021-07-29 | M | A | 5,300 | $95.80 | 289,727 | D | — | — | |
| 6 | Common | Common Stock | 2021-07-28 | M | A | 139,751 | $95.80 | 424,178 | D | — | — | |
| 7 | Derivative | Non-Qualifed Stock Option (right to buy) | 2021-07-28 | M | D | 139,751 | $95.80 | 9,493 | D | $95.80 · — to 2027-02-21 | 139,751 Common Stock | (F5) The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020. |
| 8 | Derivative | Non-Qualifed Stock Option (right to buy) | 2021-07-29 | M | D | 4,193 | $95.80 | 0 | D | $95.80 · — to 2027-02-21 | 4,193 Common Stock | (F5) The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020. |
| 9 | Derivative | Non-Qualifed Stock Option (right to buy) | 2021-07-29 | M | D | 5,300 | $95.80 | 4,193 | D | $95.80 · — to 2027-02-21 | 5,300 Common Stock | (F5) The options vested in three annual installments beginning with the first on February 21, 2018, the second on February 21, 2019 and the final on February 21, 2020. |